Compare JD.Com Inc (JD) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JD.Com Inc vs NeoGenomics Inc. Common Stock — how do they compare? JD.Com Inc trades at $26.72 (market cap $36.51B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B). The key difference: JD.Com Inc is far larger — about 16.8× NeoGenomics Inc. Common Stock's market cap, and JD.Com Inc pays a 3.73% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold JD.Com Inc for 86 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| JD | NEO | |
|---|---|---|
Market Cap | $36.51B | $2.17B |
Volume | 8,583,924 | 1,615,943 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.53 | $19.91 |
52-Week Low | $25.19 | $7.19 |
Typical Hold Time | 86 Days | 0 Days |
Enterprise Value | $19.13B | $2.47B |
Dividend Yield | 3.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JD.com trades at $26.78, up 0.22% on the day, with a bearish technical signal from moving averages but neutral oscillators. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $0.93 surpassing the $0.86 forecast. Revenue for 2025 reached $1.31 trillion, though net income margin compressed to 1.13%. The company is pursuing growth via acquisitions, such as the pending $2.5 billion Ceconomy deal, which recently gained EU approval momentum (Reuters, 2026-10-02).
The stock appears undervalued with a P/E of 17.78 and P/S of 0.2, well below sector averages. Analyst consensus is strongly bullish with a $35.38 price target, implying ~32% upside. Key risks include regulatory scrutiny in China and Europe, volatile cash flows, and competitive pressures. The robust balance sheet with $234 billion cash provides a margin of safety, but investors must weigh growth initiatives against macroeconomic headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
